Cover Image

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135

The article describes the features of the course of generalized meningococcal infection caused by W135 serogroup meningococcus in children of various age groups. Taking into account the load of the disease course, especially in children of older age, vaccination by tetravalent (A, C, W, Y) conjugate...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Ivanova (Author), N. V. Skripchenko (Author), A. A. Vilnits (Author), E. Yu. Gorelik (Author), N. V. Matyunina (Author), K. V. Serednyakov (Author)
Format:	Book
Published:	LLC "Diagnostics and Vaccines", 2016-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving the therapy of generalized forms of Meningococcal infection in children using extracorporeal hemocorrection
by: K. V. Markova, et al.
Published: (2021)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020)

Meningococcal disease serogroup C
by: Cuevas IE, et al.
Published: (2012)

Primary meningococcal arthritis of the hip due to serogroup W in a pediatric patient
by: Gabriel Dapueto, et al.
Published: (2021)

Where next? The emergence of hypervirulent W meningococcus in the Netherlands
by: Jonathan Broad, et al.
Published: (2017)

Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review
by: Claudia Palmieri, et al.
Published: (2024)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
by: Robert G. K. Donald, et al.
Published: (2017)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018)

An unexpected fever post serogroup B meningococcal sepsis
by: Daniele Donà, et al.
Published: (2016)

Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017)

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study
by: Dr Mirjam J Knol, PhD, et al.
Published: (2017)

Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)
by: L. Nicolosi, et al.
Published: (2019)

NEUROINFECTIOUS DISEASES IN CHILDREN
by: N. V. Skripchenko, et al.
Published: (2015)

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020)

Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
by: Teresa Morrone, et al.
Published: (2017)

Protecting UK adolescents and adults against meningococcal serogroup B disease
by: Andrew Vyse, et al.
Published: (2018)

Serogroup C invasive meningococcal disease in the post-vaccine era and vaccine failures
by: Neus Rius, et al.
Published: (2020)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
by: Jessica Presa, et al.
Published: (2023)

Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines
by: Chen Stein-Zamir, et al.
Published: (2019)

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
by: Paul Balmer, et al.
Published: (2018)

Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease
by: Elizabeth M. La, et al.
Published: (2019)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
by: Lidia Serra, et al.
Published: (2021)

Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin
by: Togbemabou Primous Martial Godjedo, et al.
Published: (2020)

Early neuroborreliosis in children, Bannwart syndrome (clinical observations)
by: K. V. Markova, et al.
Published: (2021)

Bacterial purulent meningitis in children: is there a light at the end of the tunnel?
by: A. A. Vilnits, et al.
Published: (2021)

The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey
by: Rahmi Tuna Tekin, et al.
Published: (2017)

Information needs during an emerging outbreak of meningococcal W135 disease in the Netherlands: a study among teenagers, their parents and healthcare professionals
by: Marion de Vries, et al.
Published: (2021)

A severe course of serogroup W meningococcemia in a patient with infantile nephropathic cystinosis
by: Gurkan Bozan, et al.
Published: (2020)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022)

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021)

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018)

Evaluation of the influence of the etiological spectrum herpesviruses into systemic and local immune response in encephalitis in children
by: E. Yu. Skripchenko, et al.
Published: (2022)

Meningococcal infection is a deadly disease: causes of death in children
by: G. P. Martynova, et al.
Published: (2024)

Nasopharyngeal Meningococcal Carriage among Children and Adolescents in Turkey in 2018: An Unexpected High Serogroup X Carriage
by: Mahmut Can Kizil, et al.
Published: (2021)

CONTEMPORARY POSSIBILITIES OF EXTRA NONSPECIFIC PROPHYLAXIS OF TICK BORN ENCEPHALITIS IN CHILDREN
by: N.V. Skripchenko, et al.
Published: (2007)

CONTEMPORARY POSSIBILITIES OF EXTRA NONSPECIFIC PROPHYLAXIS OF TICK BORN ENCEPHALITIS IN CHILDREN
by: N.V. Skripchenko, et al.
Published: (2007)

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
by: Philippe J Guerin, et al.
Published: (2008)